These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 17663409)

  • 1. Treating chronic hepatitis C virus after liver transplantation: balancing the risks against the chance for success.
    Shiffman ML
    Liver Transpl; 2007 Aug; 13(8):1088-91. PubMed ID: 17663409
    [No Abstract]   [Full Text] [Related]  

  • 2. Is there a link between hepatitis C virus and new onset of diabetes mellitus after liver transplantation?
    Thuluvath PJ
    Liver Transpl; 2007 Jan; 13(1):5-7. PubMed ID: 17192890
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of hepatitis C in patients who have decompensated cirrhosis.
    Everson GT
    Clin Liver Dis; 2005 Aug; 9(3):473-86, viii. PubMed ID: 16023978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Fifteen years of investigations on hepatitis C virus in Poland].
    Juszczyk J
    Przegl Epidemiol; 2005; 59(2):373-84. PubMed ID: 16190544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Current Guidelines for treatment of hepatitis C. The eradication of HCV as a goal].
    Sarrazin C; Zeuzem S
    Pharm Unserer Zeit; 2011 Jan; 40(1):52-9. PubMed ID: 21194083
    [No Abstract]   [Full Text] [Related]  

  • 6. Oral direct-acting antiviral therapy to prevent reinfection of the liver graft after liver transplantation for hepatitis C virus-related cirrhosis.
    Kwo PY; Tector AJ
    Liver Transpl; 2013 Jul; 19(7):780-1. PubMed ID: 23775895
    [No Abstract]   [Full Text] [Related]  

  • 7. The natural history of hepatitis C cirrhosis after liver transplantation.
    Firpi RJ; Clark V; Soldevila-Pico C; Morelli G; Cabrera R; Levy C; Machicao VI; Chaoru C; Nelson DR
    Liver Transpl; 2009 Sep; 15(9):1063-71. PubMed ID: 19718647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiviral therapy in liver transplant recipients: is SVR the only endpoint that matters?
    Kuo A; Terrault NA
    J Hepatol; 2007 Mar; 46(3):359-61. PubMed ID: 17223220
    [No Abstract]   [Full Text] [Related]  

  • 9. [Role of liver transplantation in the treatment of viral cirrhosis C].
    Duvoux C
    Gastroenterol Clin Biol; 1999 Jun; 23(5 Pt 2):B50-5. PubMed ID: 10897774
    [No Abstract]   [Full Text] [Related]  

  • 10. Cirrhosis of mixed etiology (hepatitis C virus and alcohol): Posttransplantation outcome-Comparison with hepatitis C virus-related cirrhosis and alcoholic-related cirrhosis.
    Aguilera V; Berenguer M; Rubín A; San-Juan F; Rayón JM; Prieto M; Mir J
    Liver Transpl; 2009 Jan; 15(1):79-87. PubMed ID: 19109849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aseptic osteonecrosis: a newly diagnosed complication in HIV-infected patients undergoing liver transplantation.
    Cocchi S; Franceschini E; Meschiari M; Codeluppi M; Rompianesi G; Di Benedetto F; Gerunda GE; Mussini C; Guaraldi G
    Transplantation; 2012 Aug; 94(3):e20-1. PubMed ID: 22872296
    [No Abstract]   [Full Text] [Related]  

  • 12. Ribavirin in the treatment of recurrent hepatitis C after liver transplantation: difficult to manage but essential for success.
    Samuel D; Roche B
    J Hepatol; 2007 Jun; 46(6):988-91. PubMed ID: 17445936
    [No Abstract]   [Full Text] [Related]  

  • 13. Hepatitis C virus-infected donors in liver transplantation.
    Peek R; Reddy KR
    Gastroenterology; 2007 Aug; 133(2):381-2. PubMed ID: 17681155
    [No Abstract]   [Full Text] [Related]  

  • 14. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
    Murillas J; Rimola A; Laguno M; de Lazzari E; Rascón J; Agüero F; Blanco JL; Moitinho E; Moreno A; Miró JM;
    Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Revisiting posttransplant survival for hepatitis C virus recipients.
    Kemmer N; Kaiser TE; Zacharias V; Secic M; Neff GW
    Transplantation; 2007 Oct; 84(7):932-3. PubMed ID: 17984849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The challenging patient: HCV and alcoholic liver disease.
    Lucey MR; Lake JR
    Liver Transpl; 2007 Nov; 13(11 Suppl 2):S87-8. PubMed ID: 17969072
    [No Abstract]   [Full Text] [Related]  

  • 17. Virology and pathogenesis of hepatitis C virus recurrence.
    Ramírez S; Pérez-Del-Pulgar S; Forns X
    Liver Transpl; 2008 Oct; 14 Suppl 2():S27-35. PubMed ID: 18825723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Older donors: mounting risks for the hepatitis C-infected liver transplant recipient?
    Valadao RM; Terrault NA
    Liver Transpl; 2009 Jul; 15(7):677-81. PubMed ID: 19562695
    [No Abstract]   [Full Text] [Related]  

  • 19. High rate of infection and immune disorders in patients with hepatitis C virus after liver transplantation.
    Micheloud D; Salcedo M; Bañares R; Rincón D; Jensen J; Rodríguez JJ; Fernández-Cruz E; Carbone Campoverde J; Resino S
    Transpl Infect Dis; 2009 Aug; 11(4):367-72. PubMed ID: 19497071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guide to care for patients. Hepatitis C.
    Nurse Pract; 2010 Jul; 35(7):9-10. PubMed ID: 20555235
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.